If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 165.00
Bid: 160.00
Ask: 170.00
Change: -3.50 (-2.08%)
Spread: 10.00 (6.25%)
Open: 168.50
High: 168.50
Low: 162.00
Prev. Close: 168.50
HUW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed acquisition of Pooks Limited and GM

22 Dec 2016 07:00

RNS Number : 5442S
Helios Underwriting Plc
22 December 2016
 

22 December 2016

 

Helios Underwriting plc

("Helios" or the "Company")

 

Proposed acquisition of Pooks Limited and General Meeting

 

Proposed acquisition of Pooks Limited

 

Helios is pleased to announce that, in line with its strategy of increasing underwriting capacity through acquisition, it has conditionally agreed to acquire Pooks Limited ("Pooks"), a limited liability member of Lloyd's ("LLV") which is ultimately beneficially owned by Nigel Hanbury, for a consideration of £870,659 in cash (the "Proposed Transaction"). 

 

As a result of Nigel Hanbury's indirect ownership of Upperton Holdings Limited (the shareholder of Pooks), the Proposed Transaction constitutes a substantial property transaction for the purpose of the Companies Act 2006 and, accordingly, is subject to shareholder approval. The Proposed Transaction also constitutes a related party transaction for the purpose of the AIM Rules.

 

Completion of the Proposed Transaction is conditional upon:

 

(a) the passing, without amendment, of a resolution to approve the Proposed Transaction; and

(b) Lloyd's approval of the change of control of Pooks as a result of the Proposed Transaction.

Subject to the satisfaction of the conditions, it is expected that completion of the Proposed Transaction will occur on or around 12 January 2017. If the conditions are not satisfied or waived by no later than 30 March 2017, the Acquisition Agreement will automatically terminate and cease to have any further force and effect, save in respect of any antecedent breaches of the parties under the sale and purchase agreement. 

 

Information in respect of Pooks

The 2017 underwriting capacity of Pooks is £784,666 (this compares with Helios's 2017 capacity of £32.6 million for 2017 prior to this acquisition). Pooks participates in a spread of Lloyd's syndicates that broadly matches the existing portfolio of Helios, such that no syndicate participations are expected to be relinquished or sold in the future. Pooks has a significant participation of £118,424 on the Nuclear Syndicate - Syndicate 1176 - managed by Chaucer Syndicates Limited, a high risk syndicate that has produced excellent returns in the past. This Proposed Transaction represents an opportunity for Helios to continue to build its participations on the better syndicates at Lloyd's. The capacity acquired together with the capacity retained by Helios is as follows:

 

 Pooks Ltd

 

Year of Account

 

 

 

2014

2015

2016

2017

 

£m

£m

£m

£m

Retained

0.42

0.37

0.38

0.23

Reinsured

0.42

0.37

0.38

0.55

Total Capacity

0.83

0.75

0.76

0.78

 

Pooks has entered into quota share reinsurance arrangements in respect of 50% of its portfolio for 2014 to 2016 underwriting years. These arrangements will remain in place and Helios will reinsure 70% of 2017 underwriting year in line with its stated strategy of reducing "on-risk" exposures.

 

Pooks is a limited liability member of Lloyd's. In the year ended 31 December 2015, Pooks made a profit before tax of £28,156 on gross premiums written of £606,141. Its value, as independently assessed, at completion is expected to be approximately £890,600, including underwriting capacity with an auction value of £516,071.

 

Forecasts in respect of Pooks' 2014 and 2015 open years of account are set out below:

Year of Account

Pooks

syndicate capacity

(£'000)

Forecast of syndicate profit

(30 September 2016)

Mid point

(£'000)

Mid point

(%)

Range

(%)

2014

835

150

17.98%

21.91% - 14.05%

2015

750

92

12.23%

17.17% - 7.28%

Source: Syndicate data and Helios analysis (before quota share and early release)

 

Related party transaction

As Nigel Hanbury is a director of, and substantial shareholder in, the Company, the Proposed Transaction constitutes a related party transaction for the purpose of the AIM Rules.

The Independent Directors (being the directors of Helios, other than Nigel Hanbury) consider, having consulted with the Company's nominated adviser, Stockdale Securities Limited, that the terms of the Proposed Transaction are fair and reasonable in so far as the Company's shareholders are concerned.

Posting of circular and General Meeting

The Company is posting a circular to shareholders in connection with the Proposed Transaction, including a notice of the general meeting to be held at 4.00 p.m. on Monday, 9 January 2017 at the offices of Holman Fenwick Willan LLP, Friary Court, 65 Crutched Friars, London EC3N 2AE. A copy of the circular will be made available on the Company's website (www.huwplc.com) shortly.

Commenting upon the acquisition, Sir Michael Oliver- the Chairman, said:

 

"We are delighted to have made a further acquisition which further increases our underwriting capacity. This is in line with our stated strategy of acquiring corporate members as suitable opportunities arise. The capacity on the Nuclear Syndicate - a high risk syndicate - should, in particular, help provide incremental returns to Helios."

 

For further information please contact:

 

Helios

Nigel Hanbury - Chief Executive

Arthur Manners

 

 

07787 530404 / nigel.hanbury@huwplc.com

07754 965 917

 

 

Stockdale

Robert Finlay

 

 

020 7601 6100

 

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £33 million of capacity for the 2017 account. The portfolio provides a good spread of classes of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQFEMFUFFMSEFE
Date   Source Headline
22nd Apr 20247:00 amRNSDirectorate Change
25th Mar 20242:53 pmRNSChange of Registered Office
22nd Mar 20247:00 amRNSNAV Update - 31 December 2023
4th Mar 20247:00 amRNSHelios appoints Adhiraj Maitra as COO
1st Feb 20247:00 amRNSTotal Voting Rights
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTotal Voting Rights
29th Dec 20237:00 amRNSTransaction in Own Shares
28th Dec 20237:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20234:31 pmRNSShare Repurchase Programme
15th Dec 20237:30 amRNSHelios grows 2024 portfolio to over £500m capacity
11th Dec 202310:03 amRNSTransaction in Own Shares
11th Dec 20239:59 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSNet Asset Value as at 30 September 2023
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 20237:01 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:44 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTransaction in Own Shares
8th Nov 20237:00 amRNSCapacity Value Update
7th Nov 202312:43 pmRNSNotification of Major Holdings
7th Nov 202312:38 pmRNSTransaction in Own Shares
7th Nov 20237:00 amRNSTransaction in Own Shares
6th Nov 20237:00 amRNSTransaction in Own Shares
1st Nov 20237:00 amRNSTotal Voting Rights
27th Oct 20237:00 amRNSTransaction in Own Shares
12th Oct 20237:00 amRNSTransaction in Own Shares
10th Oct 20237:00 amRNSDividend Policy & Share Repurchase Programme
4th Oct 202310:50 amRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.